Style
Aggressive GrowthTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Mirum Pharmaceuticals Inc(MIRM) | 7,679,684 | $899.1M | 19.58% |
| 2 | Newamsterdam Pharma Company(NAMS) | 18,088,902 | $613.0M | 13.35% |
| 3 | Erasca Inc(ERAS) | 24,975,188 | $457.5M | 9.96% |
| 4 | MBX Biosciences Inc(MBX) | 6,652,013 | $367.2M | 8.00% |
| 5 | Arcutis Biotherapeutics Inc(ARQT) | 9,874,511 | $258.9M | 5.64% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 85.7% | 84.66% | -1.04% |
| Unclassified | 14.3% | 15.34% | +1.04% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Trevi Therapeutics Inc(TRVI) |
| 9,939,447 |
| $185.4M |
| 4.04% |
| 7 | Krystal Biotech Inc(KRYS) | 481,307 | $178.9M | 3.90% |
| 8 | Maze Therapeutics Inc(MAZE) | 5,032,915 | $150.2M | 3.27% |
| 9 | Phathom Pharmaceuticals Inc(PHAT) | 12,466,489 | $135.3M | 2.95% |
| 10 | Palvella Therapeutics Inc NE(PVLA) | 882,400 | $134.8M | 2.94% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 51.57% | 52.43% | +0.86% |
| Small Cap | 24.97% | 27.25% | +2.28% |
| Unclassified | 14.3% | 15.34% | +1.04% |
| Large Cap | 9.06% | 3.82% | -5.24% |
| Micro Cap | 0.1% | 1.16% | +1.06% |
Quarter-over-quarter position changes